Hallux valgus: Prevalence and treatment options

外翻 外翻畸形 畸形 跖骨痛 外科 保守治疗 物理疗法 前脚 医学 并发症
作者
Sarah Ettinger,Fabian T. Spindler,Ursula Marschall,Hans Polzer,Christina Stukenborg-Colsman,Sebastian Felix Baumbach
出处
期刊:Deutsches Arzteblatt International [Deutscher Ärzte-Verlag]
标识
DOI:10.3238/arztebl.m2025.0068
摘要

Hallux valgus is a common deformity. Surgical treatment strategies have evolved markedly in recent years. We report on the administrative prevalence of this condition and the available treatments for it. The administrative prevalence of hallux valgus and the treatments provided for it in Germany were determined from data supplied by BARMER, a statutory health insurance carrier. The classification and treatment of hallux valgus are outlined in a narrative overview, with particular attention to a meta-analysis. The administrative prevalence of hallux valgus in Germany is nearly 2%; 83% of the affected persons are women. Over a 6-year period, the number of operations declined, and there was a trend toward outpatient treatment. Hallux valgus should be classified as either mild/moderate or severe. The common surgical procedures achieved comparable correction of the bony deformity. The AOFAS score improved by an average of 33.8 points (95% CI: [30.5; 37.0]) across all surgical techniques, reaching average postoperative values that ranged from 81.4±7.7 and 90.1±4.8 points depending on the particular technique used. The choice of technique and the duration of follow-up had no significant effect on the subjective treatment outcome. The overall complication rate after surgical correction was 18.5%. The common complications were metatarsalgia, recurrent deformity, stiffness of the first metatarsal joint, wound-healing disorders, and hallux varus. The primary treatment of hallux valgus should be conservative. The various surgical techniques correct the bony deformity with comparable efficacy and good postoperative AOFAS scores. Patients with more severe deformities and greater impairment seem to have a higher potential for improvement in the AOFAS score.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
axiba发布了新的文献求助10
刚刚
小猪快跑发布了新的文献求助10
刚刚
1秒前
sfx完成签到,获得积分10
1秒前
小蘑菇应助是玥玥啊采纳,获得10
2秒前
Lucas应助含糊的宛秋采纳,获得10
3秒前
3秒前
3秒前
康兴宇发布了新的文献求助10
3秒前
情怀应助suini123采纳,获得10
3秒前
长期的爽世完成签到 ,获得积分10
4秒前
尘_完成签到,获得积分10
4秒前
5秒前
Akim应助方源采纳,获得10
5秒前
6秒前
苹果一斩发布了新的文献求助10
6秒前
Stefanie发布了新的文献求助10
6秒前
谦让的沛芹完成签到,获得积分10
6秒前
8秒前
lin完成签到,获得积分10
8秒前
8秒前
8秒前
9秒前
量子星尘发布了新的文献求助150
9秒前
9秒前
西多士颗粒完成签到,获得积分10
10秒前
朴素绮琴发布了新的文献求助10
10秒前
loafing发布了新的文献求助10
10秒前
ly完成签到,获得积分10
10秒前
王艺霖发布了新的文献求助10
10秒前
Luo完成签到,获得积分10
10秒前
12秒前
方源发布了新的文献求助10
12秒前
12秒前
Alvin完成签到,获得积分10
12秒前
orixero应助Ame采纳,获得10
12秒前
小陈发布了新的文献求助10
13秒前
13秒前
13秒前
细心笑卉完成签到 ,获得积分10
13秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Hydrothermal Circulation and Seawater Chemistry: Links and Feedbacks 1200
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5154152
求助须知:如何正确求助?哪些是违规求助? 4349747
关于积分的说明 13543133
捐赠科研通 4192593
什么是DOI,文献DOI怎么找? 2299500
邀请新用户注册赠送积分活动 1299439
关于科研通互助平台的介绍 1244483